FDA advisory panel voted to allow compounding pharmacies to make 6 of 7 peptides, despite safety/efficacy concerns, with Revelation Pharma's Shawn Hodges cautiously optimistic.
July 28, 2026 10:24 AM EDT
Health Tech
The future of gray-market peptides
Shelby Livingston
Health tech correspondent
FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than…
An FDA committee will meet next month to discuss lifting a ban on a number of peptides marketed for wellness. Compounding…
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding…
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back…
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if…
Peptides are short chains of amino acids that help regulate metabolism, growth and tissue repair...
